Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes

Condition:   Type 2 Diabetes Interventions:   Combination Product: NPM-119 (exenatide implant) low dose;   Combination Product: NPM-119 (exenatide implant) high dose;   Drug: Bydureon BCise (exenatide extended release) Sponsors:   Vivani Medical, Inc;   Medpace, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials